Facts & Stats Learn more about osteoporosis and related fractures Osteoporosis is a disease characterized by low bone mass and deterioration of bone tissue which can lead to increased risk […]

Awards The Osteoporosis Canada Tim Murray Short-Term Training Awards These awards provide individuals with the opportunity to learn more about osteoporosis, advance existing research skills in osteoporosis and/or present their […]

Peace Arch Hospital, BC Peace Arch Hospital, BC Establishment of A FLS Training and Mentorship Program for the Peace Arch Hospital in B.C. Establishment of A FLS Training and Mentorship […]

Western Memorial Hospital, NL Western Memorial Hospital, NL Brookfield Chair In Fracture Prevention Funds New Fracture Liaison Service (Fls) Program In Corner Brook, Nl Brookfield Chair In Fracture Prevention Funds […]

Denosumab A human monoclonal antibody that prevents RANKL-RANK interaction Denosumab (Bone Metabolism Regulator) Denosumab is a new class of osteoporosis treatment called a human monoclonal antibody that prevents RANKL-RANK interaction […]

After rigorous peer review, the Michael Smith Foundation for Health Research (MSFHR) recently awarded the Fraser Health Authority team in British Columbia (BC), a three-year project team grant worth $500,000. […]

Romosozumab EVENITY™ (romosozumab injection) Romosozumab, a sclerostin inhibitor, is the first new approach to the treatment of osteoporosis and fracture risk in almost a decade.Romosozumab (EVENITY™) significantly and rapidly (over […]